Market research
7LV.F The Valens Company Inc
F EUR Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 261M
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- Not available
- Beta
- 1.61
Profile
Company facts
- Exchange
- F
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- ISIN
- Not available
- Market cap
- 261M
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- Not available
- Beta
- 1.61
About
About The Valens Company Inc
The Valens Company Inc. operates as a cannabis consumer products company. It engages in manufacturing cannabinoid based products. The company provides proprietary cannabis processing services, as well as is involved in product development, manufacturing, and commercialization of cannabis consumer packaged goods. Its products are formulated for the recreational, health and wellness, and medical consumer segments and offers across various cannabis product categories. The company also manufactures, distributes, and sells a range of CBD products in the United States through its subsidiary Green Roads, and distributes medicinal cannabis products to international markets through its subsidiary Valens Australia. In addition, the company through Valens Labs, provides cannabis testing and research and development services. The company was formerly known as Valens Groworks Corp. and changed its name to The Valens Company Inc. in June 2020. The Valens Company Inc. is headquartered in Toronto, Canada.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the 7LV.F discussion.
5 years, 5 months ago
The Valens Company Inc is currently in a long term uptrend where the price is trading 23.7% above its 200 day moving average.
From a valuation standpoint, the stock is 99.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.3.
The Valens Company Inc's total revenue sank by 47.6% to $16M since the same quarter in the previous year.
Its net income has dropped by 472.4% to $-17M since the same quarter in the previous year.
Finally, its free cash flow grew by 91.5% to $-599K since the same quarter in the previous year.
Based on the above factors, The Valens Company Inc gets an overall score of 3/5.